A UCSF team has harnessed a natural protein in bacteria to create a “pause switch” in immune cells, potentially leading to more effective and safer immune therapies for diseases such as cancer and multiple sclerosis. These “effector proteins” are produced by some bacteria to protect themselves from their host’s immune system and work by infiltrating immune cells and shutting down the immune response long enough to allow the bacteria to replicate.
